only 20 ppl in the study. it needs a much bigger study size. 200% pump is overdone - the results will almost certainly be more mixed in a large sample size and a proper clinical trial.
the market conditions are very insane right now.
- Forums
- ASX - By Stock
- ZLD
- Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-11
-
-
- There are more pages in this discussion • 207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
|
|||||
Last
35.0¢ |
Change
0.020(6.06%) |
Mkt cap ! $3.744M |
Open | High | Low | Value | Volume |
33.0¢ | 35.0¢ | 33.0¢ | $1.085K | 3.215K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8629 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 115 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8629 | 0.350 |
3 | 8703 | 0.330 |
2 | 1708 | 0.305 |
1 | 5000 | 0.300 |
2 | 12857 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 115 | 1 |
0.380 | 675 | 2 |
0.390 | 218 | 1 |
0.400 | 115 | 1 |
0.410 | 3837 | 2 |
Last trade - 15.45pm 03/07/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online